3 results
The purpose of this clinical trial is to demonstrate the efficacy and safety of the Rheos system in subjects with JNC-7 defined stage II hypertension that is resistant to treatment with at least three anti-hypertension agents, one of which is a…
The primary objectives of this study are to assess the performance of the Birmingham Hip Resurfacing in young active men with large femoral heads as measured with the Oxford Hip Score (OHS) and to evaluate the safety of this device as assessed by…
The primary objective of the clinical performance study is to demonstrate the clinical performance of VENTANA PD-L1 (SP263) CDx Assay in terms of its ability to identify NSCLC patients who may benefit from treatment with volrustomig plus…